Latest News and Press Releases

BASEL, Switzerland, July 21, 2005 (PRIMEZONE) --Novartis announced today that it has completed the acquisition of approximately 98 percent of U.S.-based generic pharmaceutical company Eon Labs, Inc....

BASEL, Switzerland, July 21, 2005 (PRIMEZONE) -- Novartis announced today that Zodnas Acquisition Corp., an indirect wholly owned subsidiary of Novartis AG, has successfully completed its tender...

BASEL, Switzerland, July 19, 2005 (PRIMEZONE) -- Novartis announced today that the U.S. Federal Trade Commission has accepted a Consent Decree for public comment and granted early termination of the...

BASEL, Switzerland, July 14, 2005 (PRIMEZONE) -- Novartis announced today that it has agreed to acquire the rights to a portfolio of over-the-counter (OTC) products - led by the pain medicine...

BASEL, Switzerland, July 14, 2005 (PRIMEZONE) -- Novartis AG (NYSE:NVS): -- Group first-half net sales rise 11% (+8% lc) thanks to dynamic performances by all divisions -- Strong expansion...

Pre-Planned Subset Analyses Show Femara Reduces Risk of Cancer Returning by Up to 30% in Node-Positive and Chemotherapy-Treated Patients BASEL, Switzerland, July 11, 2005 (PRIMEZONE) --...

BASEL, Switzerland, July 8, 2005 (PRIMEZONE) -- Novartis announced today that it and the other defendants in a lawsuit related to the acquisition of Eon Labs, Inc. (Nasdaq:ELAB) have reached an...

BASEL, Switzerland, July 5, 2005 (PRIMEZONE) -- Novartis announced today that Zodnas Acquisition Corp., an indirect wholly owned subsidiary of Novartis, is extending its cash tender offer to acquire...

BASEL, Switzerland and MUNICH, Germany, July 1, 2005 (PRIMEZONE) -- Data from seven clinical studies presented at the World Allergy Congress in Germany demonstrate that in patients with severe...

BASEL, Switzerland, June 30, 2005 (PRIMEZONE) -- Novartis (NYSE:NVS)announced today that it has signed an exclusive global license agreement with Arrow Therapeutics, Ltd. for A-60444 a first-in-class...